New challenges in new times

Today’s biotech and medical device companies are facing new challenges in a post-COVID world, particularly in the regulatory, clinical and commercial areas.

Since the pre-COVID era, the regulatory roadmap has gained significant importance in the product development plan, while commercial needs now play a crucial role in identifying endpoints that were previously overlooked in clinical development plans